Dian-Zhong Luo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Dian-Zhong Luo has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Gang Chen
7 shared publications- Yi-Wu Dang
Department of Pathology, The First Affiliated hospital of Guangxi Medical University, Nanning, Guangxi, China
3 shared publications Chuan-Li Su
2 shared publications- Dezhong Joshua Liao
Affiliation: Hormel Institute, University of Minnesota, Austin, Minnesota, 55912, United States of America
2 shared publications Xin-Gan Qin
2 shared publicationsYuan Sun
Hormel Institute, University of Minnesota, Austin, Minnesota, United States of America
2 shared publications
Latest Publications
- 1 January 2013
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 21 (27) , 2772
SiRNA-mediated inhibition of DcR3 gene expression induces apoptosis and reduces migration of hepatocellular carcinoma HepG2 cells
- 1 January 2013
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 21 (27) , 2772
SiRNA-mediated inhibition of DcR3 gene expression induces apoptosis and reduces migration of hepatocellular carcinoma HepG2 cells
- Open Access
- 22 August 2012
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (8) , e41659
Pseudogenes as Weaknesses of ACTB (Actb) and GAPDH (Gapdh) Used as Reference Genes in Reverse Transcription and Polymerase Chain Reactions
The genes encoding β-actin (ACTB in human or Actb in mouse) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH in human or Gapdh in mouse) are the two most commonly used references for sample normalization in determination of the mRNA level of interested genes by reverse transcription (RT) and ensuing polymerase chain reactions (PCR). In this study, bioinformatic analyses revealed that the ACTB, Actb, GAPDH and Gapdh had 64, 69, 67 and 197 pseudogenes (PGs), respectively, in the corresponding genome. Most of these PGs are intronless and similar in size to the authentic mRNA. Alignment of several PGs of these genes with the corresponding mRNA reveals that they are highly homologous. In contrast, the hypoxanthine phosphoribosyltransferase-1 gene (HPRT1 in human or Hprt in mouse) only had 3 or 1 PG, respectively, and the mRNA has unique regions for primer design. PCR with cDNA or genomic DNA (gDNA) as templates revealed that our HPRT1, Hprt and GAPDH primers were specific, whereas our ACTB and Actb primers were not specific enough both vertically (within the cDNA) and horizontally (compared cDNA with gDNA). No primers could be designed for the Gapdh that would not mis-prime PGs. Since most of the genome is transcribed, we suggest to peers to forgo ACTB (Actb) and GAPDH (Dapdh) as references in RT-PCR and, if there is no surrogate, to use our primers with extra caution. We also propose a standard operation procedure in which design of primers for RT-PCR starts from avoiding mis-priming PGs and all primers need be tested for specificity with both cDNA and gDNA.
- 22 August 2012
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (8) , e41659
Open AccessPseudogenes as Weaknesses of ACTB (Actb) and GAPDH (Gapdh) Used as Reference Genes in Reverse Transcription and Polymerase Chain Reactions
The genes encoding β-actin (ACTB in human or Actb in mouse) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH in human or Gapdh in mouse) are the two most commonly used references for sample normalization in determination of the mRNA level of interested genes by reverse transcription (RT) and ensuing polymerase chain reactions (PCR). In this study, bioinformatic analyses revealed that the ACTB, Actb, GAPDH and Gapdh had 64, 69, 67 and 197 pseudogenes (PGs), respectively, in the corresponding genome. Most of these PGs are intronless and similar in size to the authentic mRNA. Alignment of several PGs of these genes with the corresponding mRNA reveals that they are highly homologous. In contrast, the hypoxanthine phosphoribosyltransferase-1 gene (HPRT1 in human or Hprt in mouse) only had 3 or 1 PG, respectively, and the mRNA has unique regions for primer design. PCR with cDNA or genomic DNA (gDNA) as templates revealed that our HPRT1, Hprt and GAPDH primers were specific, whereas our ACTB and Actb primers were not specific enough both vertically (within the cDNA) and horizontally (compared cDNA with gDNA). No primers could be designed for the Gapdh that would not mis-prime PGs. Since most of the genome is transcribed, we suggest to peers to forgo ACTB (Actb) and GAPDH (Dapdh) as references in RT-PCR and, if there is no surrogate, to use our primers with extra caution. We also propose a standard operation procedure in which design of primers for RT-PCR starts from avoiding mis-priming PGs and all primers need be tested for specificity with both cDNA and gDNA.
- Open Access
- 1 January 2012
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 3, 93-95
A Quick, Cost-Free Method of Purification of DNA Fragments from Agarose Gel
In this short communication we report a quick, cost-free method of purification of DNA fragments from agarose gel. Unlike those procedures that involve commercial kits, this method uses glass wool or absorbent cotton to filter agarose gel during a quick spinning-down of DNA, thus significantly simplifying the routine practice of many molecular biologists and decreasing the cost.
- 1 January 2012
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 3, 93-95
Open AccessA Quick, Cost-Free Method of Purification of DNA Fragments from Agarose Gel
In this short communication we report a quick, cost-free method of purification of DNA fragments from agarose gel. Unlike those procedures that involve commercial kits, this method uses glass wool or absorbent cotton to filter agarose gel during a quick spinning-down of DNA, thus significantly simplifying the routine practice of many molecular biologists and decreasing the cost.
- 1 August 2011
- Published by Wolters Kluwer Health in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
- Vol. 19 (8) , 582-7
[Effect of miR-221 on the viability and apoptosis of hepatocellular carcinoma HepG2 cells].
To investigate the effect of microRNA-221 (miR-221) on cell viability and apoptosis of hepatocellular carcinoma HepG2 cells. MiR-221 inhibitors and mimics were transfected into HepG2 cells. The expression of miR-221 was detected by real time quantitative RT-PCR. CellTiter-blue cell viability kit, Hoechst 33342/propidium iodide (PI) double staining assay, flow cytometry and Apo-ONE homogeneous caspase-3/7 kit were used to measure cell viability and apoptosis. MiR-221 inhibitors significantly inhibited the cell growth and miR-221 mimics increased cell viability 48 hours post-transfection measured by both CellTiter-blue cell viability kit and Hoechst 33342/PI assay (P is less than to 0.05). There was a positive correlation between these two assays (r = 0.993, P is less than to 0.01). With miR-221 mimics, the number of G1 stage cells (47.67%+/-1.53%) was significantly reduced as compared to the blank control (59.00%+/-1.00%) and the negative control (58.00%+/-1.00%, F = 81.77, P is less than to 0.01), and it was significantly raised in S stage (20.33%+/-1.15%) than in blank control (11.00%+/-1.00%) and negative control (12.00%+/-1.00%, F = 70.9, P is less than to 0.01) with flow cytometry analysis. More cell apoptosis and necrosis were significantly induced by miR-221 inhibitors 48 hours post-transfection detected by both Hoechst 33342/PI assay and flow cytometry PE Annexin V kit (P is less than to 0.05). The result from Apo-ONE homogeneous caspase-3/7 kit was consistent with the above two apoptotic assays, which showed that with miR-221 inhibitors, the activity of caspase-3/7 was significantly enhanced (P is less than to 0.05). MiR-221 contributes to the growth of hepatocellular carcinoma cells and miR-221 inhibition can induce cell apoptosis. miR-221 has the potential to become one of the new molecular targets for liver cancer therapy.
- 1 August 2011
- Published by Wolters Kluwer Health in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
- Vol. 19 (8) , 582-7
[Effect of miR-221 on the viability and apoptosis of hepatocellular carcinoma HepG2 cells].
To investigate the effect of microRNA-221 (miR-221) on cell viability and apoptosis of hepatocellular carcinoma HepG2 cells. MiR-221 inhibitors and mimics were transfected into HepG2 cells. The expression of miR-221 was detected by real time quantitative RT-PCR. CellTiter-blue cell viability kit, Hoechst 33342/propidium iodide (PI) double staining assay, flow cytometry and Apo-ONE homogeneous caspase-3/7 kit were used to measure cell viability and apoptosis. MiR-221 inhibitors significantly inhibited the cell growth and miR-221 mimics increased cell viability 48 hours post-transfection measured by both CellTiter-blue cell viability kit and Hoechst 33342/PI assay (P is less than to 0.05). There was a positive correlation between these two assays (r = 0.993, P is less than to 0.01). With miR-221 mimics, the number of G1 stage cells (47.67%+/-1.53%) was significantly reduced as compared to the blank control (59.00%+/-1.00%) and the negative control (58.00%+/-1.00%, F = 81.77, P is less than to 0.01), and it was significantly raised in S stage (20.33%+/-1.15%) than in blank control (11.00%+/-1.00%) and negative control (12.00%+/-1.00%, F = 70.9, P is less than to 0.01) with flow cytometry analysis. More cell apoptosis and necrosis were significantly induced by miR-221 inhibitors 48 hours post-transfection detected by both Hoechst 33342/PI assay and flow cytometry PE Annexin V kit (P is less than to 0.05). The result from Apo-ONE homogeneous caspase-3/7 kit was consistent with the above two apoptotic assays, which showed that with miR-221 inhibitors, the activity of caspase-3/7 was significantly enhanced (P is less than to 0.05). MiR-221 contributes to the growth of hepatocellular carcinoma cells and miR-221 inhibition can induce cell apoptosis. miR-221 has the potential to become one of the new molecular targets for liver cancer therapy.
- Open Access
- 1 January 2009
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 17 (20) , 2042-2047
Clinical significance of elevated serum DcR3 in patients with hepatocellular carcinoma
目的: 探讨血清DcR3水平对HCC的诊断价值及临床意义. 方法: 采用ELISA检测67例HCC、8例肝硬化、17例胆囊炎患者和28例正常人血清DcR3水平; 化学发光法测定血清AFP水平; 免疫组织化学二步法检测HCC癌组织中DcR3蛋白的表达. 结果: HCC组和肝硬化组血清DcR3水平均明显高于正常对照组(PPr = 0.395, PP结论: 血清DcR3升高在HCC的发生发展及浸润转移中起重要作用, 通过监测高危人群以及肝癌患者血清中的DcR3水平, 同时联合检测AFP, 可能对HCC的筛查、诊断和判断预后有一定意义.
- 1 January 2009
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 17 (20) , 2042-2047
Open AccessClinical significance of elevated serum DcR3 in patients with hepatocellular carcinoma
目的: 探讨血清DcR3水平对HCC的诊断价值及临床意义. 方法: 采用ELISA检测67例HCC、8例肝硬化、17例胆囊炎患者和28例正常人血清DcR3水平; 化学发光法测定血清AFP水平; 免疫组织化学二步法检测HCC癌组织中DcR3蛋白的表达. 结果: HCC组和肝硬化组血清DcR3水平均明显高于正常对照组(PPr = 0.395, PP结论: 血清DcR3升高在HCC的发生发展及浸润转移中起重要作用, 通过监测高危人群以及肝癌患者血清中的DcR3水平, 同时联合检测AFP, 可能对HCC的筛查、诊断和判断预后有一定意义.
- 1 October 2008
- Vol. 16 (10) , 791-2
[Function of decoy receptor 3 neutralization antibody on apoptosis in hepatocellular carcinoma cells].
- 1 October 2008
- Vol. 16 (10) , 791-2
[Function of decoy receptor 3 neutralization antibody on apoptosis in hepatocellular carcinoma cells].
- Open Access
- 1 January 2008
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 16 (18)
Expression of tumor necrosis factor receptor 6 in the tissue microarrays of gastric carcinoma
目的: 探讨胃癌(gastric carcinoma, GC)组织肿瘤坏死因子受体6(tumor necrosis factor receptor 6, TR6)蛋白过度表达的临床意义. 方法: 2001/2005年手术切除或内镜活检的胃黏膜标本151例,包括慢性浅表性胃炎(CSG)42例, 胃黏膜肠上皮化生(IM)37例, 异型增生(Dys)45例, GC27例, 另外, GC52例为组织微阵列产品. 所有病例每例取2处, 作成组织微阵列6组: GC 24例、GC 27例、GC 28例、Dys 45例、IM 37例、CSG 42例. 应用免疫组织化学检测TR6蛋白的表达水平, 并分析其与临床病理特征的关系. 结果: GC组织TR6阳性率明显高于Dys、IM及CSG组织(χ2 = 2.288, P = 0.022; χ2 = 2.639, P = 0.008; χ2 = 3.593, P = 0.000). GC高分化组TR6阳性率明显低于低分化组(χ2 = 2.183, P = 0.029); TNMⅠ、Ⅱ期阳性率明显低于Ⅲ、Ⅳ期(χ2 = 2.194, P = 0.028); 无淋巴结转移组阳性率明显低于淋巴结转移组(χ2 = 2.891, P = 0.004); 无远处转移组阳性率明显低于远处转移组(χ2 = 5.021, P = 0.000); TR6表达与年龄、性别及肿瘤浸润深度无关. 结论: TR6高表达在GC的发生发展及转移中起重要作用; 检测TR6蛋白指标有助于GC诊断和判断患者预后.
- 1 January 2008
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 16 (18)
Open AccessExpression of tumor necrosis factor receptor 6 in the tissue microarrays of gastric carcinoma
目的: 探讨胃癌(gastric carcinoma, GC)组织肿瘤坏死因子受体6(tumor necrosis factor receptor 6, TR6)蛋白过度表达的临床意义. 方法: 2001/2005年手术切除或内镜活检的胃黏膜标本151例,包括慢性浅表性胃炎(CSG)42例, 胃黏膜肠上皮化生(IM)37例, 异型增生(Dys)45例, GC27例, 另外, GC52例为组织微阵列产品. 所有病例每例取2处, 作成组织微阵列6组: GC 24例、GC 27例、GC 28例、Dys 45例、IM 37例、CSG 42例. 应用免疫组织化学检测TR6蛋白的表达水平, 并分析其与临床病理特征的关系. 结果: GC组织TR6阳性率明显高于Dys、IM及CSG组织(χ2 = 2.288, P = 0.022; χ2 = 2.639, P = 0.008; χ2 = 3.593, P = 0.000). GC高分化组TR6阳性率明显低于低分化组(χ2 = 2.183, P = 0.029); TNMⅠ、Ⅱ期阳性率明显低于Ⅲ、Ⅳ期(χ2 = 2.194, P = 0.028); 无淋巴结转移组阳性率明显低于淋巴结转移组(χ2 = 2.891, P = 0.004); 无远处转移组阳性率明显低于远处转移组(χ2 = 5.021, P = 0.000); TR6表达与年龄、性别及肿瘤浸润深度无关. 结论: TR6高表达在GC的发生发展及转移中起重要作用; 检测TR6蛋白指标有助于GC诊断和判断患者预后.
- Open Access
- 1 January 2008
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 16 (23) , 2656
Expression of p14 ARF , ARF-BP1 and c-myc mRNAs in hepatocellular carcinoma and their significances
目的: 探讨肝细胞癌组织中P14ARF、ARF-BP1及c-myc的mRNA表达及其与临床参数关系. 方法: 采用半定量逆转录-聚合酶链式反应(RT-PCR)技术, 对52例HCC组织及其中45例相应癌旁组织P14ARF、ARF-BP1及c-myc的mRNA表达丰度进行检测并分析他们之间的关系及其与临床参数的关系. 结果: 在52例HCC组织中P14ARF、ARF-BP1及c-myc的mRNA各表达77.0%、77.0%和75.0%, 与45例相应癌旁组织(11.1%、20.0%、53.3%)比较, 呈高表达. P14ARF、ARF-BP1 mRNA的表达与肿瘤大小有关(t = 2.169, 2.087, 均Pc-myc mRNA表达与肿瘤大小无关. P14ARF、ARF-BP1及c-myc的mRNA表达在性别、年龄、AFP、临床病理分级、浸润转移、HBV、包膜等无统计学差异. P14ARF与ARF-BP1、P14ARF与c-myc及ARF-BP1与c-myc的mRNA表达两两成正相关(r = 0.565, 0.436, 0.584, 均P结论: P14ARF、ARF-BP1、c-myc过度表达可能是HCC发生的早期指标; ARF-BP1过度表达可能是影响HCC发生、发展的关键, 干预ARF-BP1可能是治疗HCC的新途径.
- 1 January 2008
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 16 (23) , 2656
Open AccessExpression of p14 ARF , ARF-BP1 and c-myc mRNAs in hepatocellular carcinoma and their significances
目的: 探讨肝细胞癌组织中P14ARF、ARF-BP1及c-myc的mRNA表达及其与临床参数关系. 方法: 采用半定量逆转录-聚合酶链式反应(RT-PCR)技术, 对52例HCC组织及其中45例相应癌旁组织P14ARF、ARF-BP1及c-myc的mRNA表达丰度进行检测并分析他们之间的关系及其与临床参数的关系. 结果: 在52例HCC组织中P14ARF、ARF-BP1及c-myc的mRNA各表达77.0%、77.0%和75.0%, 与45例相应癌旁组织(11.1%、20.0%、53.3%)比较, 呈高表达. P14ARF、ARF-BP1 mRNA的表达与肿瘤大小有关(t = 2.169, 2.087, 均Pc-myc mRNA表达与肿瘤大小无关. P14ARF、ARF-BP1及c-myc的mRNA表达在性别、年龄、AFP、临床病理分级、浸润转移、HBV、包膜等无统计学差异. P14ARF与ARF-BP1、P14ARF与c-myc及ARF-BP1与c-myc的mRNA表达两两成正相关(r = 0.565, 0.436, 0.584, 均P结论: P14ARF、ARF-BP1、c-myc过度表达可能是HCC发生的早期指标; ARF-BP1过度表达可能是影响HCC发生、发展的关键, 干预ARF-BP1可能是治疗HCC的新途径.
- 1 April 2007
- Vol. 15 (4) , 302-3
[The relationship between the expression of TR6 mRNA and protein in the apoptosis of hepatocellular carcinoma cells].
- 1 April 2007
- Vol. 15 (4) , 302-3
[The relationship between the expression of TR6 mRNA and protein in the apoptosis of hepatocellular carcinoma cells].
- 1 February 2007
- Vol. 36 (2) , 113-7
[Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
To study the expression of decoy receptor 3 (DcR3) and its relationship with apoptosis and prognosis in hepatocellular carcinoma (HCC). The expression of DcR3 protein in 43 cases of HCC and 16 cases of non-cancerous liver (including cirrhotic liver tissue and normal liver tissue adjacent to cavernous hemangioma) was studied by immunohistochemistry (using EnVision method). The status of apoptosis was evaluated by terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) technique. Statistic analysis was carried out to assess the correlation between DcR3 expression, apoptotic index (AI) and clinicopathologic parameters. DcR3 protein was expressed in the cytoplasm of HCC cells. The positivity rate of DcR3 in HCC was 74.42% (32/43), which was significantly higher than that in the non-cancerous group (43.75%, P < 0.05). The positivity rate of DcR3 in HCC with metastasis detected within 20 months of diagnosis was 100% (22/22). This was significantly higher than that in HCC without metastasis (52.94%, P < 0.01). The DcR3 expression in HCC also correlated with serum alpha-fetoprotein level (r = 0.444, P < 0.01) and presence of tumor embolus in portal vein (r = 0.414, P < 0.01). However it had no relationship with the patient's age, sex, cirrhotic status, liver capsule invasion, number of tumor nodules and histologic differentiation (P > 0.05). The AI in HCC (0.78 +/- 0.64)% was significantly lower than that in the non-cancerous group [(3.32 +/- 1.81)%, P < 0.01]. The AI in clinical TNM stage I and II tumors (1.03 +/- 0.69)% was significantly higher than that in stage III and IV tumors [(0.52 +/- 0.48)%, P < 0.01]. The AI in HCC without metastasis (1.10 +/- 0.72)% was significantly higher than that in HCC without metastasis [(0.44 +/- 0.27)%, P < 0.05]. The AI correlated with serum alpha-fetoprotein level (r = -0.468, P < 0.01), presence of tumor embolus in portal vein (r = -0.434, P < 0.01) and liver capsule invasion (r = -0.331, P < 0.05). On the other hand, it had no relationship with patient's age, sex, cirrhotic status, number of tumor nodules and histologic differentiation (P > 0.05). The AI in DcR3-positive group (including both HCC and non-cancerous tissues) was significantly lower than that in DcR3-negative group (P < 0.01). The expression of DcR3 in HCC correlates with apoptosis of tumor cells and may play a crucial role in tumor pathogenesis and progression. DcR3 protein expression and AI may also serve as important biologic indicators in predicting prognosis of HCC.
- 1 February 2007
- Vol. 36 (2) , 113-7
[Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
To study the expression of decoy receptor 3 (DcR3) and its relationship with apoptosis and prognosis in hepatocellular carcinoma (HCC). The expression of DcR3 protein in 43 cases of HCC and 16 cases of non-cancerous liver (including cirrhotic liver tissue and normal liver tissue adjacent to cavernous hemangioma) was studied by immunohistochemistry (using EnVision method). The status of apoptosis was evaluated by terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) technique. Statistic analysis was carried out to assess the correlation between DcR3 expression, apoptotic index (AI) and clinicopathologic parameters. DcR3 protein was expressed in the cytoplasm of HCC cells. The positivity rate of DcR3 in HCC was 74.42% (32/43), which was significantly higher than that in the non-cancerous group (43.75%, P < 0.05). The positivity rate of DcR3 in HCC with metastasis detected within 20 months of diagnosis was 100% (22/22). This was significantly higher than that in HCC without metastasis (52.94%, P < 0.01). The DcR3 expression in HCC also correlated with serum alpha-fetoprotein level (r = 0.444, P < 0.01) and presence of tumor embolus in portal vein (r = 0.414, P < 0.01). However it had no relationship with the patient's age, sex, cirrhotic status, liver capsule invasion, number of tumor nodules and histologic differentiation (P > 0.05). The AI in HCC (0.78 +/- 0.64)% was significantly lower than that in the non-cancerous group [(3.32 +/- 1.81)%, P < 0.01]. The AI in clinical TNM stage I and II tumors (1.03 +/- 0.69)% was significantly higher than that in stage III and IV tumors [(0.52 +/- 0.48)%, P < 0.01]. The AI in HCC without metastasis (1.10 +/- 0.72)% was significantly higher than that in HCC without metastasis [(0.44 +/- 0.27)%, P < 0.05]. The AI correlated with serum alpha-fetoprotein level (r = -0.468, P < 0.01), presence of tumor embolus in portal vein (r = -0.434, P < 0.01) and liver capsule invasion (r = -0.331, P < 0.05). On the other hand, it had no relationship with patient's age, sex, cirrhotic status, number of tumor nodules and histologic differentiation (P > 0.05). The AI in DcR3-positive group (including both HCC and non-cancerous tissues) was significantly lower than that in DcR3-negative group (P < 0.01). The expression of DcR3 in HCC correlates with apoptosis of tumor cells and may play a crucial role in tumor pathogenesis and progression. DcR3 protein expression and AI may also serve as important biologic indicators in predicting prognosis of HCC.